The analysis of 3 dozen studies found similarities and differences in motivating factors for and against clinical trial ...

The antibody is tailored for RA patients who have not responded well to existing treatments, including anti-tumour necrosis factor (TNF) therapies. The first-in-human, adaptive design, randomised ...

In line with previous clinical trial findings, real-world data show that bevacizumab improves outcomes in patients with ...

Calquence (acalabrutinib) plus bendamustine and rituximab reduced risk for disease progression or death by 27% compared with ...

AbolerIS Pharma has dosed the Phase I study’s first cohort subjects with its humanised anti-CD45 receptor-like protein C ...

Many men with metastatic hormone-sensitive prostate cancer have not received recommended first-line treatment. Physicians reported not giving recommended treatment based on guidelines and safety ...

Weight-loss drugs and bariatric surgery both have an impact on cancer risk. A new study breaks down the link and how GLP-1 RAs may help prevent the disease.

Less than three weeks after AstraZeneca and Daiichi Sankyo reported positive results for oncology powerhouse Enhertu in a ...

A study of more than 100 patients found that immunotherapy can cure a rare type of cancer in various tumor sites without ...

Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry ...

Learn more about platelets, small types of blood cells that prevent excessive bleeding and serve other important purposes.